drugset / Trial / NCT00005787
Peripheral Stem Cell Transplantation to Prevent Neutropenia in Patients Receiving Chemotherapy for Relapsed or Refractory Non-Hodgkin's Lymphoma
Supportive care
Summary
RATIONALE: Peripheral stem cell transplantation may be able to replace immune cells that were destroyed by chemotherapy used to kill cancer cells. Treating the peripheral stem cells in the laboratory may improve the effectiveness of the transplant. PURPOSE: Phase I trial to study the effectiveness of peripheral stem cell transplantation in patients who have relapsed or refractory non-Hodgkin's lymphoma and who will be treated with high-dose chemotherapy.
Timeline
- Start
- 1999-09
- Primary completion
- 2002-01
- Completion
- 2002-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Background | epoetin alfa | Protein / enzyme biologic | — | — |
| Background | filgrastim | Protein / enzyme biologic | — | — |
| Background | flt3 ligand | Protein / enzyme biologic | — | — |
| Background | interleukin-3 | Protein / enzyme biologic | — | — |
| Background | sargramostim | Protein / enzyme biologic | — | — |